These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 38623973)
1. Synthesis of Rupestonic Acid L-Ephedrine Derivatives with Preliminary Yong J; Lu C Curr Pharm Des; 2024; 30(18):1398-1403. PubMed ID: 38623973 [TBL] [Abstract][Full Text] [Related]
2. Novel amides modified rupestonic acid derivatives as anti-influenza virus reagents. Li G; Obul M; Zhao JY; Liu GY; Lu W; Aisa HA Bioorg Med Chem Lett; 2019 Oct; 29(19):126605. PubMed ID: 31439378 [TBL] [Abstract][Full Text] [Related]
3. Structural modification on rupestonic acid leads to highly potent inhibitors against influenza virus. Obul M; Wang X; Zhao J; Li G; Aisa HA; Huang G Mol Divers; 2019 Feb; 23(1):1-9. PubMed ID: 29971616 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and anti-influenza activity of aminoalkyl rupestonates. Zhao J; Aisa HA Bioorg Med Chem Lett; 2012 Mar; 22(6):2321-5. PubMed ID: 22341943 [TBL] [Abstract][Full Text] [Related]
5. 1,2,3-Triazole-containing derivatives of rupestonic acid: click-chemical synthesis and antiviral activities against influenza viruses. He YW; Dong CZ; Zhao JY; Ma LL; Li YH; Aisa HA Eur J Med Chem; 2014 Apr; 76():245-55. PubMed ID: 24583605 [TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship studies of 1-(1'-hydroxyalkyl)rupestonic acid methyl esters against influenza viruses. Li G; Zhao JY; Niu C; Nie LF; Dong CZ; Aisa HA Bioorg Med Chem Lett; 2017 Mar; 27(6):1484-1487. PubMed ID: 28196702 [TBL] [Abstract][Full Text] [Related]
7. Advances in studies on the rupestonic acid derivatives as anti-influenza agents. Yong J; Lu C; Aisa HA Mini Rev Med Chem; 2013 Feb; 13(2):310-5. PubMed ID: 22625417 [TBL] [Abstract][Full Text] [Related]
8. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012-2013 season. Ikematsu H; Kawai N; Iwaki N; Kashiwagi S J Infect Chemother; 2015 Jan; 21(1):39-42. PubMed ID: 25277670 [TBL] [Abstract][Full Text] [Related]
9. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase. Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558 [TBL] [Abstract][Full Text] [Related]
10. Rupestonic acid derivative YZH-106 suppresses influenza virus replication by activation of heme oxygenase-1-mediated interferon response. Ma LL; Wang HQ; Wu P; Hu J; Yin JQ; Wu S; Ge M; Sun WF; Zhao JY; Aisa HA; Li YH; Jiang JD Free Radic Biol Med; 2016 Jul; 96():347-61. PubMed ID: 27107768 [TBL] [Abstract][Full Text] [Related]
11. In vitro neuraminidase inhibitory activities of four neuraminidase inhibitors against influenza viruses isolated in the 2010-2011 season in Japan. Ikematsu H; Kawai N; Kashiwagi S J Infect Chemother; 2012 Aug; 18(4):529-33. PubMed ID: 22370919 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of novel L-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors. Wang H; Xu R; Shi Y; Si L; Jiao P; Fan Z; Han X; Wu X; Zhou X; Yu F; Zhang Y; Zhang L; Zhang L; Zhou D; Xiao S Eur J Med Chem; 2016 Mar; 110():376-88. PubMed ID: 26866456 [TBL] [Abstract][Full Text] [Related]
14. Antiviral Activity of Benzoic Acid Derivative NC-5 Against Influenza A Virus and Its Neuraminidase Inhibition. Guo M; Ni J; Yu J; Jin J; Ma L; Zhang H; Wang D; Zhang X; Dou J; Zhou C Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31842256 [TBL] [Abstract][Full Text] [Related]
15. Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors. Li Z; Meng Y; Xu S; Shen W; Meng Z; Wang Z; Ding G; Huang W; Xiao W; Xu J Bioorg Med Chem; 2017 May; 25(10):2772-2781. PubMed ID: 28385598 [TBL] [Abstract][Full Text] [Related]
16. Design, in silico studies, synthesis and in vitro evaluation of oseltamivir derivatives as inhibitors of neuraminidase from influenza A virus H1N1. Neri-Bazán RM; García-Machorro J; Méndez-Luna D; Tolentino-López LE; Martínez-Ramos F; Padilla-Martínez II; Aguilar-Faisal L; Soriano-Ursúa MA; Trujillo-Ferrara JG; Fragoso-Vázquez MJ; Barrón BL; Correa-Basurto J Eur J Med Chem; 2017 Mar; 128():154-167. PubMed ID: 28182988 [TBL] [Abstract][Full Text] [Related]
17. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against influenza virus isolates in the 2011-2012 season in Japan. Ikematsu H; Kawai N; Iwaki N; Kashiwagi S J Infect Chemother; 2014 Feb; 20(2):77-80. PubMed ID: 24560563 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and bioassay of 4-thiazolinone derivatives as influenza neuraminidase inhibitors. Xiao M; Xu L; Lin D; Lian W; Cui M; Zhang M; Yan X; Li S; Zhao J; Ye J; Liu A; Hu A Eur J Med Chem; 2021 Mar; 213():113161. PubMed ID: 33540229 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of Novel Chiral Sulfonamide-Bearing 1,2,4-Triazole-3-thione Analogs Derived from D- and L-Phenylalanine Esters as Potential Anti-Influenza Agents. Başaran E; Karaküçük-Iyidoğan A; Schols D; Oruç-Emre EE Chirality; 2016 Jun; 28(6):495-513. PubMed ID: 27225330 [TBL] [Abstract][Full Text] [Related]
20. Antiviral activity of a synthesized shikonin ester against influenza A (H1N1) virus and insights into its mechanism. Zhang Y; Han H; Qiu H; Lin H; Yu L; Zhu W; Qi J; Yang R; Pang Y; Wang X; Lu G; Yang Y Biomed Pharmacother; 2017 Sep; 93():636-645. PubMed ID: 28688289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]